Revenue from Contracts with Customers (Tables)

6 Months Ended

Jun. 30, 2025

Revenue from Contract with Customer [Abstract]

Schedule of Disaggregation of Revenue

The following table summarizes revenue by source as follows:

	Three Months Ended June 30,				Six Months Ended June 30,
(in thousands)	2025		2024		2025		2024
Major Products /Service Lines
Product revenue, net(1)	$	374,547	$	392,756	$	741,465	$	762,069
License and royalty revenues		3,498		1,335		9,344		1,997
Total revenues	$	378,045	$	394,091	$	750,809	$	764,066

(1)The Company’s product revenue includes PYLARIFY and DEFINITY among other products. This category represents the delivery of physical goods. The Company applies the same revenue recognition policies and judgments for all its principal products.

Revenue by product category on a net basis is as follows:

	Three Months Ended June 30,				Six Months Ended June 30,
(in thousands)	2025		2024		2025		2024
PYLARIFY	$	250,642	$	273,255	$	508,296	$	532,125
Other radiopharmaceutical oncology		—		—		—		384
Total radiopharmaceutical oncology		250,642		273,255		508,296		532,509
DEFINITY		83,939		78,100		163,150		154,664
TechneLite		24,982		28,186		44,693		49,900
Other precision diagnostics		6,892		5,825		12,333		11,757
Total precision diagnostics		115,813		112,111		220,176		216,321
Strategic partnerships and other revenue		11,590		8,725		22,337		15,236
Total revenues	$	378,045	$	394,091	$	750,809	$	764,066